Abbott Laboratories Financials

Abbott Laboratories

ABT • NYSE •

Values in thousands	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Revenue	$9,964,000	$10,241,000	$10,143,000	$9,978,000
Gross Profit	5,544,000	5,258,000	5,538,000	5,495,000
EBITDA	1,450,000	2,677,000	2,593,000	2,463,000
EBIT	639,250	1,864,000	1,769,000	1,663,000
Net Income	1,225,000	1,594,000	1,436,000	1,375,000
Net Change In Cash	9,964,000	10,241,000	10,143,000	9,978,000
Cost of Revenue				-1,299,000
Free Cash Flow	627,000	2,283,000	1,317,000	696,000
Cash	6,284,000	6,896,000	6,709,000	7,835,000
Basic Shares	1,750,000	1,748,000	1,748,289	1,750,248

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$40,109,000	$43,653,000	$43,075,000	$34,608,000
Gross Profit	22,134,000	24,511,000	24,538,000	19,605,000
EBITDA	10,585,000	10,696,000	10,749,000	7,592,000
EBIT	7,342,000	8,362,000	8,425,000	5,357,000
Net Income	5,723,000	6,933,000	7,071,000	4,495,000
Net Change In Cash	40,109,000	43,653,000	43,075,000	34,608,000
Cost of Revenue		205,000	3,031,000	2,907,000
Free Cash Flow	5,059,000	7,804,000	8,648,000	5,724,000
Cash	6,896,000	9,882,000	9,799,000	6,838,000
Basic Shares	1,749,000	1,764,000	1,789,000	1,786,000